Canterbury DHB


Chemotherapy and Emetogenic Potential

See eviQ for international guidelines in prevention of antineoplastic-induced nausea and vomiting.

High (>90% risk)

Moderate (30-90% risk)

Low (10-30% risk)

Minimal (<10%)

About this Canterbury DHB document (9326):

Document Owner:

Sean Macpherson (see Who's Who)

Last Reviewed:

January 2019

Next Review:

January 2022


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 9326